Screener
Ligand Pharmaceuticals LGND Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
FAQ
- What is Ligand Pharmaceuticals's net margin?
- Ligand Pharmaceuticals (LGND) reported net margin of 67.9% in Q2 2026.
- How has Ligand Pharmaceuticals's net margin changed year-over-year?
- Ligand Pharmaceuticals's net margin increased by 267.8% year-over-year, from -40.4% to 67.9%.
- What is the long-term trend for Ligand Pharmaceuticals's net margin?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's net margin has grown at a 96.1% compound annual growth rate (CAGR), from -1.6% to 46.4%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Ligand Pharmaceuticals's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude